Literature DB >> 33585370

Lower CMV and EBV Exposure in Children With Kawasaki Disease Suggests an Under-Challenged Immune System.

Diana van Stijn-Bringas Dimitriades1, Annemarie Slegers1, Hans Zaaijer2, Taco Kuijpers1.   

Abstract

Background: Kawasaki Disease (KD) is a pediatric vasculitis of which the pathogenesis is unclear. The hypothesis is that genetically pre-disposed children develop KD when they encounter a pathogen which remains most often unidentified or pathogen derived factors. Since age is a dominant factor, prior immune status in children could influence their reactivity and hence the acquisition of KD. We hypothesized that systemic immune responses early in life could protect against developing KD. With this study we tested whether the incidence of previous systemic cytomegalovirus (CMV) or Epstein-Barr virus (EBV) infection is lower in children with KD compared to healthy age-matched controls. Methods and
Results: We compared 86 KD patients with an age-matched control group regarding CMV and EBV VCA IgG measurements (taken before or 9 months after IVIG treatment). We found that both CMV and EBV had an almost 2-fold lower seroprevalence in the KD population than in the control group. Conclusions: We suggest that an under-challenged immune system causes an altered immune reactivity which may affect the response to a pathological trigger causing KD in susceptible children.
Copyright © 2021 van Stijn-Bringas Dimitriades, Slegers, Zaaijer and Kuijpers.

Entities:  

Keywords:  Epstein-Barr virus; Kawasaki disease; cytomegalovirus; immune system; viral exposure

Year:  2021        PMID: 33585370      PMCID: PMC7873854          DOI: 10.3389/fped.2020.627957

Source DB:  PubMed          Journal:  Front Pediatr        ISSN: 2296-2360            Impact factor:   3.418


  98 in total

1.  Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease.

Authors:  Luisa Berenise Gamez-Gonzalez; Isabel Moribe-Quintero; Martin Cisneros-Castolo; Javier Varela-Ortiz; Mireya Muñoz-Ramírez; Martin Garrido-García; Marco Yamazaki-Nakashimada
Journal:  Pediatr Int       Date:  2018-09       Impact factor: 1.524

2.  Reduced serologic response to mumps, measles, and rubella vaccination in patients treated with intravenous immunoglobulin for Kawasaki disease.

Authors:  Carline E Tacke; Gaby P Smits; Fiona R M van der Klis; Irene M Kuipers; Hans L Zaaijer; Taco W Kuijpers
Journal:  J Allergy Clin Immunol       Date:  2013-03-14       Impact factor: 10.793

3.  Isolation of human herpesvirus-6 from an infant with Kawasaki disease.

Authors:  K Hagiwara; T Yoshida; H Komura; F Kishi; T Kajii
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183

4.  Common variants in CASP3 confer susceptibility to Kawasaki disease.

Authors:  Yoshihiro Onouchi; Kouichi Ozaki; Jane C Buns; Chisato Shimizu; Hiromichi Hamada; Takafumi Honda; Masaru Terai; Akihito Honda; Takashi Takeuchi; Shoichi Shibuta; Tomohiro Suenaga; Hiroyuki Suzuki; Kouji Higashi; Kumi Yasukawa; Yoichi Suzuki; Kumiko Sasago; Yasushi Kemmotsu; Shinichi Takatsuki; Tsutomu Saji; Tetsushi Yoshikawa; Toshiro Nagai; Kunihiro Hamamoto; Fumio Kishi; Kazunobu Ouchi; Yoshitake Sato; Jane W Newburger; Annette L Baker; Stanford T Shulman; Anne H Rowley; Mayumi Yashiro; Yoshikazu Nakamura; Keiko Wakui; Yoshimitsu Fukushima; Akihiro Fujino; Tatsuhiko Tsunoda; Tomisaku Kawasaki; Akira Hata; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Hum Mol Genet       Date:  2010-04-27       Impact factor: 6.150

5.  Breast milk is not a significant source for early Epstein-Barr virus or human herpesvirus 6 infection in infants: a seroepidemiologic study in 2 endemic areas of human T-cell lymphotropic virus type I in Japan.

Authors:  K Kusuhara; A Takabayashi; K Ueda; Y Hidaka; I Minamishima; H Take; K Fujioka; S Imai; T Osato
Journal:  Microbiol Immunol       Date:  1997       Impact factor: 1.955

6.  Tendency toward atopy in Kawasaki disease.

Authors:  S Matsuoka; K Tatara; R Nakagawa; K Mori; Y Kuroda
Journal:  Eur J Pediatr       Date:  1997-01       Impact factor: 3.183

7.  CD40 Gene polymorphisms associated with susceptibility and coronary artery lesions of Kawasaki disease in the Taiwanese population.

Authors:  Ho-Chang Kuo; Mei-Chyn Chao; Yu-Wen Hsu; Ying-Chi Lin; Ying-Hsien Huang; Hong-Ren Yu; Ming-Feng Hou; Chi-Di Liang; Kuender D Yang; Wei-Chiao Chang; Chih-Lu Wang
Journal:  ScientificWorldJournal       Date:  2012-05-02

Review 8.  Kawasaki disease: what is the epidemiology telling us about the etiology?

Authors:  David Burgner; Anthony Harnden
Journal:  Int J Infect Dis       Date:  2005-07       Impact factor: 3.623

9.  Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry.

Authors:  Brian W McCrindle; Cedric Manlhiot; Jane W Newburger; Ashraf S Harahsheh; Therese M Giglia; Frederic Dallaire; Kevin Friedman; Tisiana Low; Kyle Runeckles; Mathew Mathew; Andrew S Mackie; Nadine F Choueiter; Pei-Ni Jone; Shelby Kutty; Anji T Yetman; Geetha Raghuveer; Elfriede Pahl; Kambiz Norozi; Kimberly E McHugh; Jennifer S Li; Sarah D De Ferranti; Nagib Dahdah
Journal:  J Am Heart Assoc       Date:  2020-07-28       Impact factor: 5.501

10.  Biomarkers for the Discrimination of Acute Kawasaki Disease From Infections in Childhood.

Authors:  Judith Zandstra; Annemarie van de Geer; Michael W T Tanck; Diana van Stijn-Bringas Dimitriades; Cathelijn E M Aarts; Sanne M Dietz; Robin van Bruggen; Nina A Schweintzger; Werner Zenz; Marieke Emonts; Dace Zavadska; Marko Pokorn; Effua Usuf; Henriette A Moll; Luregn J Schlapbach; Enitan D Carrol; Stephane Paulus; Maria Tsolia; Colin Fink; Shunmay Yeung; Chisato Shimizu; Adriana Tremoulet; Rachel Galassini; Victoria J Wright; Federico Martinón-Torres; Jethro Herberg; Jane Burns; Michael Levin; Taco W Kuijpers
Journal:  Front Pediatr       Date:  2020-07-22       Impact factor: 3.569

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.